Skip to main content
SpringerLink
Log in

Ditane und Gepante

Migräne: Zwei neue Substanzen zur Akuttherapie und Prävention

Migraine: New options in acute therapy and prophylaxis

  • FB_Seminar
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Neurologische Klinik / Oberbayer. Kopfschmerzzentrum, Klinikum Großhadern der LMU München, Marchioninistr. 15, 81377, München, Germany

    Andreas Straube

  2. Klinik und Poliklinik für Neurologie, Campus Großhadern der LMU München, Marchioninistr. 15, 81377, München, Germany

    Ruth Ruscheweyh

Authors
  1. Andreas Straube
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ruth Ruscheweyh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Straube.

Ethics declarations

AS: Für Vortragstätigkeit und Beratung: Allergan, Novartis, Lundbeck, Lilly, Sanofi, TEVA

Forschungsunterstützung: Novartis, Innovationsfonds, DFG, Universität München

RR: Für Vortragstätigkeit und Beratung: Allergan, Hormosan, Novartis, Lilly, Lundbeck, Teva

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Straube, A., Ruscheweyh, R. Migräne: Zwei neue Substanzen zur Akuttherapie und Prävention. MMW - Fortschritte der Medizin 165, 60–62 (2023). https://doi.org/10.1007/s15006-023-2877-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-023-2877-0

Keywords:

Search

Navigation